ArticleBlood advances2022

Genome-wide CRISPR/Cas9 screening identifies determinant of panobinostat sensitivity in acute lymphoblastic leukemia.

Chuang Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.